Xeris
Xeris is an Illinois-based pharmaceutical company that develops and commercializes liquid-stable injectables for the treatment of diabetes and epilepsy.
Business Model:
Revenue: $98.2M
Employees: 201-500
Industries / Tags:
Detailed Xeris Information
Geographic Data
Address: 180 North LaSalle Street
City: Chicago
State: IL
Zip: 60601
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$30M
Raised Total:$290M
Social
Metrics
3,099,777Website Global Rank
5,402Website Monthly Traffic
Twitter Followers
Description
Xeris is an Illinois-based pharmaceutical company that develops and commercializes liquid-stable injectables for the treatment of diabetes and epilepsy.
Contact Phone:
+18444455704
Contact Email:
Xeris went public on 6/20/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/20/2018
IPO Valuation:
$296M
Ticker Symbol:
XERS
IPO Price:
$15/share
Amount Raised:
$86M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2021 | Strongbridge Biopharma |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
